NYP – At least one prominent hedge fund mogul who played the now-busted $55 billion AbbVie-Shire deal got out in the nick of time, The Post has learned.
Eric Mindich, one of a handful of hedgies who cut their trading teeth on Goldman Sachs’ risk arb desk, told investors that his Eton Park Capital hedge fund decided to take its profits in Shire in September because of the risks associated with the deal.
